GBS 

$0.47
43
-$0-0.57% Thursday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.5
-0.53
0.43
1.4
Expected EPS
1.4
Actual EPS
N/A

Financials

-2,727,650.34%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
177.79Revenue
-4.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GBS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific offers a broad range of services and products for research, analysis, discovery, and diagnostics, directly competing with INBS's offerings in the biotech and healthcare solutions space.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering similar products and technologies that compete with INBS's portfolio.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. specializes in DNA sequencing and array-based technologies, competing with INBS in the genomic analysis and diagnostics sectors.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. provides a variety of instruments and reagents for research and clinical diagnostic applications, directly competing with INBS in the life sciences and healthcare market.
Agilent Technologies
A
Mkt Cap32.66B
Agilent Technologies, Inc. offers instruments, services, consumables, applications, and expertise, competing with INBS in areas such as diagnostics and genomics.
Waters
WAT
Mkt Cap29.85B
Waters Corporation produces analytical standards and instruments, including for chromatography and mass spectrometry, competing with INBS in the analytical and diagnostics sectors.
Bruker
BRKR
Mkt Cap5.6B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing with INBS in providing comprehensive solutions for the biotech industry.
Guardant Health
GH
Mkt Cap12.31B
Qiagen NV
QGEN
Mkt Cap8.46B
QIAGEN N.V. offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with INBS in the field of molecular diagnostics and research.

About

GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Show more...
CEO
Employees
7
Country
US
ISIN
US36151G1058
WKN
000A2QK2J

Listings

0 Comments

Share your thoughts

FAQ

What is GBS stock price today?
The current price of GBS is $0.47 USD — it has decreased by -0.57% in the past 24 hours. Watch GBS stock price performance more closely on the chart.
What is GBS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange GBS stocks are traded under the ticker GBS.
What is GBS revenue for the last year?
GBS revenue for the last year amounts to 177.79 USD.
What is GBS net income for the last year?
GBS net income for the last year is -4.85M USD.
How many employees does GBS have?
As of April 06, 2026, the company has 7 employees.
In which sector is GBS located?
GBS operates in the Manufacturing sector.
When did GBS complete a stock split?
GBS has not had any recent stock splits.
Where is GBS headquartered?
GBS is headquartered in New York, US.